Kee-Young Shin

7PUBLICATIONS
99CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsRadiation therapyMedical virology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 09, 2026
Phase 1 trial and biomarker analysis of Buparlisib with weekly Cisplatin and Radiotherapy in high risk locally advanced squamous cell cancer of the Head and Neck.

|Aug 21, 2026
Ultrasensitive circulating tumor DNA analysis improves detection of molecular residual disease in locally advanced esophageal cancer.

|Oct 09, 2025
Elraglusib, a Glycogen Synthase Kinase 3β Inhibitor, plus Chemotherapy with or without Immunotherapy in Patients with Recurrent, Metastatic Salivary Gland Carcinoma.

Glenn J Hanna, Nicole Scarfo, Kee-Young Shin

|Jul 11, 2025
Stereotactic Radiosurgery in Patients With Small Cell Lung Cancer and 1-10 Brain Metastases: A Multi-Institutional, Phase II, Prospective Clinical Trial.

Ayal A Aizer, Shyam K Tanguturi, Diana D Shi

|Dec 03, 2024
Duvelisib with Docetaxel for Patients with Anti-PD-1 Refractory, Recurrent, or Metastatic Head and Neck Squamous Cell Carcinoma.

Glenn J Hanna, L B Oakley, R Shi

|Oct 29, 2024
AI-derived Tumor Volume from Multiparametric MRI and Outcomes in Localized Prostate Cancer.

David D Yang, Leslie K Lee, James M G Tsui

Pageof 2

Frequent Collaborators

3 joint publications

Glenn J Hanna

3 joint publications

Anne O'Neill

3 joint publications

Kristine Wong

3 joint publications

Robert I Haddad